News

Morganroth is currently working as ERT’s chairman and chief scientific officer and has served as the chairman of ERT’s board of directors since 1999 and as chief scientific

The application relates to the use of Ergothioneine compositions containing one or more additional nutraceutical compounds to improve a variety of health related factors, including, but not limited

Janssen-Cilag International has also filed a marketing authorisation application (MAA) with the European Medicines Agency for abiraterone acetate. Abiraterone acetate was developed by Ortho Biotech Oncology Research &

The study results revealed that INC424 provided a statistically significant reduction in spleen size in patients with primary MF, post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia myelofibrosis (PET-MF).

Mantecorp, controlled by Brazil’s Mantegazza family, is based in Rio de Janeiro state. Mantecorp has a portfolio of prescription and non-prescription drugs, as well as a line of

The Japan patent covers Rexahn’s preclinical compound RX-0047 and a method of inhibiting the expression of HIF-1 in human cells or tissues. HIF-1, a human protein is involved

Theobromine, a metabolite of caffeine, has been used as a vasodilator (a blood vessel widener), a diuretic (urination aid) and heart stimulant. Theobromine has been shown to inhibit

Alferon N Injection is Hemispherx’s natural FDA approved interferon injection product for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries

Glenmark‘s extended-release Felodipine tablets are available in strengths of 2.5 mg, 5 mg and 10 mg and are indicated for the treatment of hypertension. Glenmark will commence marketing